Leica Biosystems has launched its new HistoCore LIGHTNING C Laser Cassette Printer, designed to help laboratories standardise critical histopathology workflows, improve traceability and move from sample to answer with greater speed and certainty.
The HistoCore LIGHTNING C Laser Cassette Printer addresses current challenges in consistency and traceability at the front end of histopathology workflows by delivering fast, consistent and durable specimen identification at the very start. Reliable cassette identification is critical to maintaining traceability throughout the diagnostic process, yet traditional labelling methods can introduce inconsistency, manual steps and ongoing maintenance demands.
Designed for use with validated Leica Biosystems cassettes, the system uses high-quality UV laser printing to produce clear and durable markings, including barcodes and 2D codes, to support reliable traceability as samples move from processing through diagnosis. With printing speeds of up to 2.5 seconds per cassette and capacity for up to 600 cassettes, laboratories can optimise throughput, reduce bottlenecks and maintain workflow continuity, even under growing demand.
By eliminating the need for ink and ribbons, the system helps laboratories reduce maintenance requirements, minimise downtime and lower total cost of ownership. Automated colour recognition and LIS compatibility further optimise operations by matching cassette colour to predefined templates, reducing manual intervention and helping prevent identification errors so laboratories can standardise critical foundational workflow steps.
“Histopathology laboratories are often expected to do more with limited time, space and resources, while still needing confidence that every specimen is accurately identified across the diagnostic journey,” said Anupama Mokkapati, Senior Vice President of Core Portfolio and Global Supply Chain at Leica Biosystems. “The HistoCore LIGHTNING C Laser Cassette Printer helps laboratories enhance foundational workflow steps by combining speed, durable print quality and seamless integration to support accurate, timely results to patients.”
As part of Danaher’s connected ecosystem of life sciences and diagnostics companies, Leica Biosystems supports nearly two million cancer tests globally each week and is the only provider of end-to-end solutions across the anatomic pathology workflow - helping laboratories standardise and connect critical steps from sample to answer with greater speed, confidence and traceability.
Cassettes included are intended for in vitro diagnostic use only.